BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16489028)

  • 1. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis.
    Henderson MA; Danks JA; Slavin JL; Byrnes GB; Choong PF; Spillane JB; Hopper JL; Martin TJ
    Cancer Res; 2006 Feb; 66(4):2250-6. PubMed ID: 16489028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases.
    Bouizar Z; Spyratos F; Deytieux S; de Vernejoul MC; Jullienne A
    Cancer Res; 1993 Nov; 53(21):5076-8. PubMed ID: 8221637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis.
    Bouizar Z; Spyratos F; De vernejoul MC
    J Bone Miner Res; 1999 Mar; 14(3):406-14. PubMed ID: 10027905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
    Mihai R; Stevens J; McKinney C; Ibrahim NB
    Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites.
    Powell GJ; Southby J; Danks JA; Stillwell RG; Hayman JA; Henderson MA; Bennett RC; Martin TJ
    Cancer Res; 1991 Jun; 51(11):3059-61. PubMed ID: 2032246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer.
    Southby J; Kissin MW; Danks JA; Hayman JA; Moseley JM; Henderson MA; Bennett RC; Martin TJ
    Cancer Res; 1990 Dec; 50(23):7710-6. PubMed ID: 2253214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone related protein in breast cancers of widely varying prognosis.
    Kissin MW; Henderson MA; Danks JA; Hayman JA; Bennett RC; Martin TJ
    Eur J Surg Oncol; 1993 Apr; 19(2):134-42. PubMed ID: 8491317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer.
    Iddon J; Bundred NJ; Hoyland J; Downey SE; Baird P; Salter D; McMahon R; Freemont AJ
    J Pathol; 2000 Jun; 191(2):170-4. PubMed ID: 10861577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PTHrP and breast cancer].
    Devys A; Lortholary A; Audran M
    Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PTHrP and bone sialoprotein as prognostic markers for developing bone metastases in breast cancer patients].
    Loibl S; Königs A; Kaufmann M; Costa SD; Bischoff J
    Zentralbl Gynakol; 2006 Dec; 128(6):330-5. PubMed ID: 17213971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-related peptide: expression in prostate cancer bone metastases.
    Bryden AA; Islam S; Freemont AJ; Shanks JH; George NJ; Clarke NW
    Prostate Cancer Prostatic Dis; 2002; 5(1):59-62. PubMed ID: 15195132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization.
    Vargas SJ; Gillespie MT; Powell GJ; Southby J; Danks JA; Moseley JM; Martin TJ
    J Bone Miner Res; 1992 Aug; 7(8):971-9. PubMed ID: 1442211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
    Bundred NJ; Walls J; Ratcliffe WA
    Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of metastatic spread in triple-negative breast cancer.
    Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
    Breast Cancer Res Treat; 2009 May; 115(2):423-8. PubMed ID: 18543098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
    Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival.
    Linforth R; Anderson N; Hoey R; Nolan T; Downey S; Brady G; Ashcroft L; Bundred N
    Clin Cancer Res; 2002 Oct; 8(10):3172-7. PubMed ID: 12374685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.